Giron Development 2025: Value Moved Higher, but the Real Test Is Cash, Leasing and Refinancing

Getting To Know The Company

Giron Development is not a listed-equity growth story and it is not a broadly diversified institutional landlord. It is a bond-only public debt issuer with 20 income-producing properties in Israel, around 122.3 thousand sqm of leasable area, and a fairly simple economic engine built on rent, maintenance income, and funding. The easy 2025 reading is to look at comprehensive income of NIS 161.2 million and at the NIS 151.6 million uplift in investment-property value. That is only half the picture.

What is working today is the core portfolio. Revenue rose to NIS 126.5 million, total NOI reached NIS 101.8 million, nominal FFO rose to NIS 52.4 million, the equity-to-assets ratio climbed to 51.6%, and the company still reports roughly 330 tenants with no single tenant contributing 10% or more of consolidated revenue. What is not clean is the layer between value and liquidity. Cash and cash equivalents fell from NIS 262.1 million to NIS 37.7 million, working capital moved to a NIS 175.3 million deficit, and a fully repaid Series V bond stack was replaced in part by a NIS 165 million short-term bank line.

That is why the right way to read Giron in 2025 is not as a breakout year but as a bridge year. The operating business held up, but the bottleneck moved elsewhere: can the company term out short and more expensive funding, re-lease vacated areas, and show that the value created on paper, especially at Sapir, can eventually become NOI, FFO, and accessible cash.

The quick economic map matters more than the headline profit line:

Another key point is that floor area and profit mix are not the same thing. Industrial and storage account for 67% of area, offices and clinics for 18%, and retail for 15%. But the 2025 NOI mix is 40% retail, 38% industrial and storage, and 22% offices and clinics. In other words, anyone reading the portfolio only by square meters misses where profitability actually sits.

Asset Concentration

Giron does not rely on one tenant, but it does rely on a handful of assets. Ashkelon Mall alone is valued at NIS 520.2 million, about 27% of the investment-property portfolio, and generated NIS 32.9 million of 2025 NOI, roughly 32% of the total. Add Beit HaUmot, Beit Giron, Beit Avgad, and the Sapir complex, and the top five assets account for about 61.9% of portfolio value.

Events And Triggers

The big 2025 event is not a sharp jump in NOI. It is a shift in the center of gravity from the profit line to the financing line.

Trigger one: the company booked NIS 151.6 million of revaluation gains in 2025 versus NIS 62.6 million in 2024. That was not a broad-based move across the portfolio. It was heavily concentrated. The Sapir complex alone contributed NIS 87.6 million, almost 58% of the year's total revaluation gain. That matters because the same asset produced only NIS 2.0 million of revenue and NIS 1.6 million of NOI in 2025. The value step-up is therefore not yet matched by operating income.

This becomes even more important because the year-end valuation appendix says Sapir was already valued at NIS 151.6 million as of September 30, 2025, and that there was no change by December 31, 2025. The main accounting move has already happened. The next proof point is not another appraisal, but execution.

Trigger two: Series V was fully repaid on December 31, 2025. That cleans up one debt layer, but it also changed the liquidity picture. The repayment was bridged with NIS 165 million of short-term bank credit. So while the balance sheet became stronger in equity terms, near-term funding became tighter in practical terms.

Trigger three: 2025 and early 2026 also marked a management transition. In May 2025, Destiny, the controlling shareholder up the chain, became a reporting bond issuer. In February 2026, Ron Avidan became CEO while Avraham Roichman moved from CEO to active chairman. That is not a control change, but it is a change in the execution interface and in the way the group is managed.

Efficiency, Profitability And Competition

The operating numbers are not weak, but they do not support a clean narrative of an organic earnings breakout. Revenue rose from NIS 125.0 million to NIS 126.5 million, up just 1.2%. Gross profit was almost flat at NIS 101.7 million versus NIS 101.8 million in 2024. That means the true operating improvement was modest, and most of the 2025 story sits above the operating core rather than inside it.

What actually drove the numbers

The revenue increase came mainly from CPI-linked rent escalation, lease renewals, the leasing of vacant areas in some assets, and especially better performance at Beit HaUmot in Jerusalem. That matters because it means growth was driven mostly by pricing mechanics and occupancy recovery, not by a major expansion in the asset base.

On the other side, cost of revenue rose to NIS 24.8 million, mainly because of security, cleaning, and municipal charges. G&A also climbed to NIS 18.2 million. The core business therefore held up, but it did not open a major margin gap.

Earnings quality

This is where the real difference sits. Net income jumped to NIS 161.2 million, but nominal FFO, a more relevant metric for recurring income property economics, only rose to NIS 52.4 million. More notably, management-view FFO fell to NIS 68.3 million from NIS 72.3 million in 2024. That decline does not mean the real estate business suddenly weakened. It reflects the fact that management's extra adjustments, especially the add-back of CPI linkage on financial liabilities, provided less uplift in 2025 than in 2024.

This is the heart of the story. A reader looking only at the bottom line sees a breakout. A reader looking at FFO sees something much more restrained, and that is the better way to judge the year's quality.

What the occupancy picture hides

On a full-year basis the portfolio looks solid: Ashkelon Mall averaged 99% occupancy, Beit HaUmot averaged 98%, and industrial/storage averaged 94% by use. But the year-end snapshot is less comfortable. By use, occupancy at December 31, 2025 stood at 84% in retail, 98% in industrial and storage, and 86% in offices and clinics.

The gap between the annual average and the year-end picture matters because it suggests that the run-rate entering 2026 is softer than the annual NOI line alone implies. Beit Avgad is the clearest case. A tenant occupying about 26% of the asset's leasable area vacated in August 2025. The company notes that the revenue contribution from that tenant was below 2% of consolidated revenue, but end-period occupancy in the asset dropped to 67%. At the same time, the asset's value rose to NIS 152 million and it recorded NIS 18.4 million of revaluation gains. That is exactly where paper value and leased cash flow begin to diverge.

The moat is real, but not deep

The company's own framing is correct. Entry barriers are relatively low, new properties can be built, and a large part of the portfolio is older stock. Against that, Giron does have real advantages: decent locations in a number of assets, in-house management that saves cost, and no single tenant dominating the business.

So the competitive position is moderate. This is not a rare premium portfolio, but neither is it a weak one. The implication is that Giron cannot lean only on "value" or only on a story. It still has to deliver leasing, collections, and refinancing.

Cash Flow, Debt And Capital Structure

This is where Giron's live bottleneck sits. Covenants are not tight, the balance sheet is not weak, but financial room narrowed sharply on an all-in basis.

Cash flow, using an all-in cash flexibility lens

To avoid mixing recurring earning power with actual financial flexibility, the better framework here is all-in cash flexibility, meaning what is left after the period's real cash uses.

In 2025 the company generated NIS 80.1 million from operating activities. That shows the business still throws off cash. But the uses then matter: roughly NIS 40 million of investment in property and fixed assets, NIS 20 million of dividends, and NIS 411.7 million of bond repayments. The gap was bridged by NIS 165 million of new short-term bank borrowing and by a sharp decline in cash balances.

The implication is straightforward: the business is not operating under distress, but the room left after all real uses became much tighter. This is also where the NIS 20 million dividend looks legally fine yet economically less comfortable. The company complied with every distribution restriction. Still, in a year when cash fell sharply and a bank bridge was added, that payout consumed another layer of cushion.

Debt, covenants, and what is actually heavy

Total financial debt at year-end stood at NIS 651.5 million, made up of NIS 486.5 million of bonds and NIS 165 million of short-term bank debt. Against that stood NIS 57.8 million of cash and short-term investments. That is not an immediately threatening leverage level against NIS 1.908 billion of investment property and an unencumbered asset base. But it is a meaningful change in debt composition.

The price of money matters as well. Series Z carries a 1.9% nominal coupon linked to CPI. Series H carries only 0.39% nominal linked to CPI. The new bank bridge is floating-rate debt at 5.5% to 6.5%. So even if covenant headroom is very wide, the move from long and relatively cheap bond funding to shorter and costlier bank funding changes the economics.

There is a real positive side too. The company sits far above covenant floors. Consolidated equity reached NIS 1.04 billion versus minimums of NIS 325 million for Series Z and NIS 385 million for Series H. The equity-to-assets ratio was 51.6% versus a 25% floor. The bonds remain rated A1 with a stable outlook. And the company states that all of its assets are unencumbered.

The solo layer matters here

Because Giron is a bond-only issuer, the parent-company layer matters. On a solo basis, cash and cash equivalents were just NIS 25.8 million at year-end 2025, but the parent also received NIS 46.9 million of dividends from subsidiaries during the year. The company further states that there are no material restrictions on cash transfers within the group. That is why the working-capital deficit does not automatically mean a liquidity problem. It does, however, make 2026 a real financing year rather than an easy one.

Outlook

There is no detailed formal guidance in the style of a growth company. So the next year has to be read from what the numbers allow, from the signed rent base, and from the practical bottlenecks that remain open.

The five points that matter for 2026

Point one: 2026 looks like a bridge year, not a harvest year. The operating core is stable, but a large share of 2025 improvement already came through revaluations. The next year needs more proof and less appraisal.

Point two: the asset that created most of the value, the Sapir complex, is still barely generating NOI. As long as that remains the case, that value is more planning-driven than cash-driven.

Point three: wide covenant headroom does not solve duration. The near-term market read will focus on whether the NIS 165 million bank line is refinanced in time and at an acceptable cost.

Point four: there is a reasonable contractual base. Minimum future rents under signed leases amount to NIS 103.3 million for the first year and NIS 154.2 million for years two through five. That is not full protection, but it does provide visibility.

Point five: the year-end occupancy snapshot, especially in retail and offices, means the company needs to re-prove that roughly NIS 100 million of NOI is sustainable without another unusually large valuation uplift.

What actually has to happen

The first step is debt refinancing. Without that, even a relatively solid asset portfolio will keep reading as a financing story. The company itself says it can refinance through additional bonds or bank debt, and it leans on the fact that its assets are unencumbered. That is credible, but it is still not execution.

The second step is leasing. Late 2025 showed point-specific softness, especially at Beit Avgad. If those areas are re-leased on sound terms, the market can read 2025 as a successful bridge year. If not, the gap between fair value and NOI will start to matter more.

The third step is to turn planning value into operating value. Ashkelon Mall carries additional building rights valued at about NIS 14.9 million. Sapir has already seen its value jump. In both cases, the real question is not whether the rights are worth something on paper, but whether they become a project, occupancy, or monetization.

So the next phase looks much more like a financing and cash-conversion proof year than a breakout year.

Risks

The central risk heading into 2026 is not covenant breach. It is the possibility that the debt market or the banks force Giron into refinancing that is pricier, shorter, or slower than the company wants. A NIS 165 million short-term bank line at 5.5% to 6.5% is not catastrophic, but it does alter the comfort level.

The second risk is the gap between paper value and cash earnings. When 2025 relies heavily on revaluation gains, led by NIS 87.6 million at Sapir, any delay in converting that value into NOI or into a real project makes the year's improvement look less durable.

The third risk is occupancy and tenant churn. Despite roughly 330 tenants and no tenant above 10% of revenue, the company states that three tenants, each occupying 100% of a specific income-producing asset, together accounted for about 10% of consolidated revenue. A cluster of departures without timely replacement would matter.

The fourth risk is inflation and interest rates. The company still has NIS 486.5 million of CPI-linked bonds, and CPI linkage created NIS 18.2 million of financing expense in 2025. The company argues that CPI-linked rents provide long-term protection. That is fair, but in shorter periods, especially with a layer of floating-rate bank debt added on top, the effect on cash flow and funding cost can still be uncomfortable.

There is also an asset-specific risk worth remembering. In an asset in Carmiel, leased to a single tenant, legal proceedings are ongoing around a purchase option, and the company carries the asset at the option value out of caution. This is not the core Giron thesis, but it is a reminder that not every asset in the portfolio is frictionless.

---

Conclusion

Giron exits 2025 in an interesting place, not clean but not weak either. The property business itself held up well, the balance sheet became stronger, and covenant headroom is wide. At the same time, the big improvement in earnings leaned heavily on revaluations, while financing moved from a more comfortable long bond layer to a shorter and costlier bank bridge. So the next few quarters will be decided less by whether the value is "real" and more by whether it becomes cash, occupancy, and a sensible debt duration profile.

Current thesis in one line: Giron's operating core is stable, but the value created in 2025 now has to be tested through cash, leasing, and refinancing.

What changed versus the simple read of the company: Giron can no longer be read only as a stable income-property portfolio. In 2025 it added a large layer of planning-led value, especially at Sapir, while replacing retired debt with a shorter bank bridge.

The strongest counter-thesis: the company has unencumbered assets, wide covenant room, stable rating support, and positive operating cash flow, so the current financing pressure may prove to be technical rather than structural.

What could change the market's reading in the short to medium term: orderly refinancing of the NIS 165 million bank line, re-leasing of vacated space, and evidence that NOI can hold around NIS 100 million even without another outsized revaluation year.

Why this matters: because at Giron the key question is no longer whether the assets contain value, but how much of that value is actually reachable by creditors and the equity layer through cash generation, occupancy, and funding access.

Over the next 2 to 4 quarters the company needs to show three things: that short funding can be term-extended, that late-2025 leasing softness was not the start of a wider deterioration, and that assets such as Sapir move one step closer to income rather than staying mostly in the valuation appendix. If that happens, 2025 will look like a successful bridge year. If not, it will remain a strong revaluation year with an open question on cash quality.